Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
EmGenisys logo — Breeding Something Epic

EmGenisys

Breeding Something Epic

Founded 2019 United States Houston, United States 6 employees Seed Total: $2.00M Agriculture, Biotechnology +3

General Information

Company Name EmGenisys
Founded Year 2019
Location United States Houston, United States
Employees 6
Industries Agriculture, Biotechnology, Health Care +2
Funding Stage Seed
Business Model SaaS, B2B, Platform
Revenue Model Subscription, Usage Based, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with EmGenisys. To contact EmGenisys, visit emgenisys.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does EmGenisys compare?

A PDF of EmGenisys and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting EmGenisys soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About EmGenisys

EmGenisys, founded in 2019 and headquartered in the United States, operates at the intersection of Agriculture, Biotechnology, and AgriTech. The company is dedicated to enhancing livestock production through innovative technology. Its flagship product is a SaaS solution that offers a noninvasive analysis of embryo morphokinetic activity, aimed at improving pregnancy outcomes via assisted reproductive techniques.

With a motto of "Breeding Something Epic," EmGenisys stands out for its unique approach to advancing health care in the agricultural sector. Although their last recorded investment was a modest $4.00K Grant from Texas A&M Innovation on 19 May 2022, the company shows promise in a niche that is becoming increasingly important.

EmGenisys's focus on life sciences and health care within agriculture positions it well to tap into broader trends seeking sustainable or technologically enhanced agricultural solutions.

Business keywords: reproductive advancements, embryo health assessment, sustainable production, animal welfare, precision technology, video motion magnification, embryo viability, sex determination, animal production improvement, reproductive technologies, animal science, embryology, bovine reproduction, equine reproduction

Services & Products

Data-driven Embryo Analysis
Embryo Health Evaluation
Machine Learning Platform for Embryo Selection

Target Customers

Animal Producers Livestock Farmers Agricultural Industry Veterinarians

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $1.50M 3
Tall Grass Ventures Grit Road Partners
Tall Grass Ventures, Grit Road Partners +1
01 Jul 2025
Grant $250.00K 1
BioTools Innovator
BioTools Innovator
01 Sep 2024
Grant $250.00K 2
Grow-NY
Grow-NY, Luminate Accelerator
01 Jun 2022

EmGenisys Alternatives & Competitors

View All Alternatives
EmGenisys vs
Trans Ova Genetics
Trans Ova Genetics United States

Multiply Success

250 employees
Biotechnology, Health Care
EmGenisys vs
Vytelle
Vytelle United States

The most accessible, reliable and predictable solution to drive sustainable genetic progress.

Series B
104 employees
Agriculture, Biotechnology
Compare EmGenisys vs Vytelle
EmGenisys vs
Episona
Episona United States

Episona is an epigenetic data company focused on improving reproductive health outcomes. Episona’s f...

Seed
1 employees
Biotechnology, Health Care
View all alternatives

FAQ About EmGenisys

Breeding Something Epic
EmGenisys was founded in 2019.
EmGenisys is headquartered in Houston, United States.
EmGenisys operates in Agriculture, Biotechnology, Health Care, Life Sciences and AgriTech. Its work centres on reproductive advancements, embryo health assessment, sustainable production and animal welfare. Its customers include Animal Producers, Livestock Farmers and Agricultural Industry.
EmGenisys has a SaaS, B2B and Platform business model. Its revenue comes from Subscription, Usage Based and Tiered Pricing.
EmGenisys has approximately 6 employees.
EmGenisys has completed 3 funding rounds, raising a total of $2.00M. The latest funding stage is Seed.
EmGenisys offers: Data-driven Embryo Analysis, Embryo Health Evaluation, Machine Learning Platform for Embryo Selection.
Top alternatives and competitors to EmGenisys include Trans Ova Genetics, Vytelle, Episona, OXOLIFE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EmGenisys and Trans Ova Genetics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EmGenisys, https://bouncewatch.com/company/emgenisys, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout